Intravitreal injections: taking the plunge

29 October 2021
Autumn 2021

Increasing demand for intravitreal injections to treat conditions such as wet AMD provides an opportunity for optometrists to widen their portfolio of skills, writes Kim Thomas.

Part of the success of the COVID-19 vaccination programme was down to the many optometrists and other healthcare professionals who helped deliver the vaccine. Now the programme is nearing its end, could optometrists use their newly acquired skills to take on another role – that of intravitreal injector?

Sign in to continue

Forgotten password?

Not already a member of The College?

Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

Our Editor in Chief, Professor Leon Davies FCOptom, looks back at what's been another challenging year.

This edition takes a look at the risk variants and genetic distribution of Age-related macular degeneration as well as topical ivermectin-metronidazole gel therapy for blepharitis caused by Demodex.

This article reviews the research into digital technology innovation and home monitoring in the management of age-related macular degeneration (AMD) and glaucoma.